ArticleJournal of robotic surgery2025
Adnexal mass management by minimally invasive surgery at a comprehensive cancer center.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates methods of specimen extraction, pertinent clinical data and pathologic findings associated with minimally invasive surgery (MIS) for adnexal masses. This retrospective cohort study includes patients with an adnexal mass who underwent MIS removal. The association of categorical variables with adverse outcomes was investigated using Pearson chi-square or Fisher's exact test. Four hundred and thirty-eight patients met inclusion criteria. Surgical modalities included laparoscopic (n = 235, 53.7%), robotic (n = 165, 37.7%), and vaginal (n = 1, 0.2%). MIS was converted to laparotomy in 37 cases (8.4%). 203 (46.3%) specimens were removed vaginally, and 235 (53.7%) abdominally. Three hundred and nineteen (72.8%) specimens were removed intact whereas 119 (27.2%) were morcellated or drained 113 contained). Of the 6 uncontained morcellation cases, one was ovarian cancer, and one was a borderline tumor. For malignant histologies, receipt of adjuvant chemotherapy was not associated with specimen integrity (455 intact vs 12 morcellated, p = 0.207), route of specimen removal (31 vaginal vs 36 abdominal, p = 0.217), or use of a specimen bag (46 bag vs 21 no bag, p = 0.105). This study demonstrated that MIS is feasible in the majority of patients referred to our cancer center for an adnexal mass. Perioperative complications were uncommon. Management of the ovarian malignancies encountered in this cohort was not compromised by utilization of MIS.
Indexed as
Identifiers
41108488What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.